Overview

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 163 Cr
Volatility: Low Risk
P/E Ratio: 0.0
Industry P/E: 33.7
PEG Ratio: —
P/B Ratio: 2.6
52W High: 128.60
52W Low: 101.50

Sales CAGR

1Y: 150.49%
3Y: —
5Y: —
10Y: —

Profit CAGR

1Y: 291.60%
3Y: —
5Y: —
10Y: —

ROE

TTM: 66.48%
3Y: 57.11%
5Y: —
10Y: —

ROCE

TTM: 47.70%
3Y: 47.50%
5Y: —
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
QUESTLAB		101.15	166 Cr	11.04	1.71	0.00	15.51	19.06	13.51
NATCAPSUQ		157.00	163 Cr	-7.78	0.74	0.00	-7.27	-4.85	-5.82
KIMIABL		34.25	162 Cr	21.82	9.15	0.00	41.95	22.81	7.20
BMLL		128.60	162 Cr	12.05	2.61	0.00	66.48	47.70	0.00
PANCHSHEEL		120.15	160 Cr	14.78	1.14	0.00	7.69	9.73	6.30
ACHYUT		6.59	159 Cr	548.45	4.54	0.00	0.90	1.13	0.76
AUROLAB		253.00	158 Cr	91.91	3.68	0.00	4.47	7.31	1.55
Median: 7 Co.	—	120.15	162 Cr	14.78	2.61	0.00	7.69	9.73	1.55

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2023	Mar 2024	Mar 2025
Sales	16	15	38
Expenses	15	9.62	23
Operating Profit	1.70	5.63	15
OPM %	10.47	36.93	39.83
Other Income	0.02	0.09	0.13
Interest	0.77	0.97	1.20
Depreciation	0.50	1.11	1.01
Profit Before Tax	0.45	3.65	13
Tax %	26.23	31.55	25.47
Net Profit	0.33	2.50	9.79
EPS in Rs	—	—	—
Dividend Payout %	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.10	0.10	9.18
Reserves	2.34	4.84	5.55
Borrowings	9.61	10	15
Other Liabilities	5.52	4.10	9.37
Total Liabilities	18	20	39
Fixed Assets	8.31	8.73	7.68
CWIP	0.00	0.00	0.00
Investments	0.00	0.00	0.00
Other Assets	9.26	11	31
Total Assets	18	20	39

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	2.29	1.62	-3.67
Cash from Investing Activity	-1.69	-1.54	0.34
Cash from Financing Activity	-2.13	-0.08	3.33
Net Cash Flow	-1.52	0.00	-0.00

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Aug 2025	May 2026
Promoters	100.00%	67.70%
FIIs	0.00%	0.29%
DIIs	0.00%	2.31%
Public	0.00%	29.71%
Total Shareholders	7	1,195

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Bio Medica Laboratories Ltd

Bio Medica Laboratories Ltd (BMLL) is currently trading at 130.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Bio Medica Laboratories Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.

Over the past 52 weeks, Bio Medica Laboratories Ltd has traded between a low of ₹101.50 and a high of ₹128.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Bio Medica Laboratories Ltd has a market capitalization of approximately 161.71. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Bio Medica Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 161.71 Cr, Bio Medica Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Bio Medica Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Bio Medica Laboratories Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Bio Medica Laboratories Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison